Franklin Genomic Advancements ETF (HELX) Price, Holdings, & News

ETF Overview

The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that is based on the Solactive Genomics index. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is managed by Franklin Templeton.

Key Stats

• Today's Range: $29.62 to $29.91
• 50-Day Range: $28.85 to $31.11
• 52-Week Range: N/A
• Volume: 3,729 shs
• Average Volume: N/A
• Market Capitalization: $9.03 million
• Assets Under Management: $12.05 million
• Dividend Yield: N/A
• Net Expense Ratio: 0.50%
• Aggregate Rating: Moderate Buy

HELX ETF - Frequently Asked Questions

How have HELX shares performed this year?

Franklin Genomic Advancements ETF's stock was trading at $28.85 at the start of the year. Since then, HELX shares have increased by 4.3% and is now trading at $30.0850.
View the best growth stocks for 2025 here.

Who are Franklin Genomic Advancements ETF's major shareholders?

Franklin Genomic Advancements ETF's top institutional shareholders include Jane Street Group LLC (13.68%), LPL Financial LLC (5.66%), Citadel Advisors LLC (2.66%) and Halbert Hargrove Global Advisors LLC (0.60%).

How do I buy shares of Franklin Genomic Advancements ETF?

Shares of HELX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Franklin Genomic Advancements ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Franklin Genomic Advancements ETF investors own include Merck & Co., Inc. (MRK), Abiomed (ABMD), Catalent (CTLT), iShares iBonds Dec 2025 Term Muni Bond ETF (IBMN), Net Element (NETE), Novavax (NVAX) and AbbVie (ABBV).

Fund Details

• Issuer: Franklin Templeton Investments
• Fund Name: Franklin Genomic Advancements ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: BATS
• Current Symbol: BATS:HELX
• Inception Date: 2/25/2020
• Fund Manager: Matthew J.Moberg, Joyce Lin
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: N/A
• Category: Strategy
• Focus: Theme
• Development Level: Blended Development
• Region: Global
• Number of Holdings: 70

Fund Statistics

• Assets Under Management: $12.05 million
• Average Daily Volume: $0.00
• Discount/Premium: 0.02%

Administrator, Advisor and Custodian

• Administrator: Franklin Templeton Services, LLC
• Advisor: Franklin Advisers, Inc.
• Custodian: State Street Bank and Trust Company
• Distributor: Franklin Templeton Distributors, Inc.
• Transfer Agent: State Street Bank and Trust Company
• Trustee: N/A
• Lead Market Maker: Citadel

Miscellaneous

• Outstanding Shares: 300,000
• Beta: 1.00
• Creation Unit: 50,000
• Creation Fee: $200.00